SILCS-RNA: Toward a Structure-Based Drug Design Approach for Targeting RNAs with Small Molecules

Area of Science:

• Computational chemistry
• Structural biology
• Drug discovery

Background:

• RNA molecules are crucial drug targets due to their roles in disease.
• Noncoding RNAs, with complex structures, offer opportunities for small molecule targeting.

Purpose of the Study:

• To extend the SILCS computational approach for targeting RNA molecules.
• To develop and validate a method for identifying small molecule binding sites on RNA.

Main Methods:

• Site Identification by Ligand Competitive Saturation for RNA (SILCS-RNA).
• Utilized enhanced oscillating excess chemical potential and Monte Carlo simulations.
• Calculated SILCS functional group affinity maps (FragMaps) for binding site identification and docking.

Main Results:

• SILCS-RNA accurately characterized functional group affinities in known RNA binding sites.
• The method identified new potential binding sites and key ligand binding moieties.
• Demonstrated utility in facilitating small molecule ligand design for RNA targets.

Conclusions:

• SILCS-RNA enhances computational drug design for RNA targets.
• The approach aids in identifying binding sites and guiding ligand optimization.
• Acknowledged limitations in mapping phosphate groups and RNA conformational heterogeneity.